Report Highlights
The U. S. market for clinical healthcare IT technologies was more than $9.5 billion in 2011 and nearly $11.2 billion in 2012. The market is projected to grow to $26.1 billion in 2017, a compound annual growth rate (CAGR) of 18.5% over the next five years.
Report Includes
- An overview of the market for selected clinical healthcare information technologies (IT) in the context of ongoing dramatic changes in the structure of the U.S. healthcare sector.
- Analyses of market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017.
- Estimations of the size of each market segment.
- Coverage of clinical IT systems that facilitate or provide input into the care process, as opposed to administrative and financial systems.
- Comprehensive company profiles of major players.
Report Scope
This report is an analytical business tool whose primary purpose is to describe and analyze the dynamics of the U.S. market for healthcare technology. It is particularly focused on clinical IT systems that facilitate or provide input into the care process, as opposed to administrative and financial systems. It covers only software applications, as well as dedicated hardware and online services used to run them.
The study format includes these major elements:
- Executive summary.
- Definitions.
- Clinical healthcare IT applications.
- Benefits and barriers to implementation.
- Market environment (e.g., legal and regulatory standards, economic conditions, consumer attitudes).
- Historical (i.e., 2011 and 2012) and projected markets for healthcare IT technologies and products through 2017.
- Industry structure.
Analyst Credentials
Andrew McWilliams spent more than 25 years as a consultant with Ernst & Young, McKinsey & Company and A.T. Kearny focused on manufacturing before segueing into research analysis. He has been covering myriad technology categories for BCC Research for more than 15 years. McWilliams has a BA from Princeton University and an MA from Harvard University. He has worked in more than 40 countries and he resides in the greater Boston area.
Report Highlights
BCC estimates the total market for the clinical healthcare IT technologies covered in this report at more than $6.3 billion in 2010. The market is projected to grow to approximately $7.4 billion in 2011 and nearly $17.5 billion in 2016, a compound annual growth rate (CAGR) of 18.7% over the next 5 years.
Report Highlights
- The U.S. market for healthcare IT is expected to be worth $4.0 billion in 2009. This should increase to $9.0 billion in 2014, a compound annual growth rate (CAGR) of 17.5%.
- The software applications segment dominates the market, generating an estimated $3.4 billion in 2009. This should increase to $7.2 billion in 2014, for a CAGR of 16.4%.
- Dedicated hardware is the second largest segment, worth an estimated $636.8 million in 2009. This should increase to $1.8 billion in 2014, for a CAGR of 22.9%.
Report Highlights
-
BCC estimates the U.S. healthcare IT market size at $16.38 billion in 2005 and forecasts that it will grow to $18.5 billion in 2006. By 2011 it is expected to reach $34.7 billion in sales, a 13.4% AAGR.
-
The hospital segment accounts for the larger portion of the market with 52.2% of sales in 2005, 51.4% in 2006 and 48.2% in 2011. The Physician/ home care/ nursing/ hospices sector will overtake hospitals by the end of the forecast period and will be worth 51.3% of the U.S. market by 2011.
-
The highest growth appears in physicians, home care, nursing homes, and hospices. The market for this sector of the industry was worth more than $7.7 billion in 2005. By the end of 2006 it will grow to almost $8.9 billion and, at an AAGR of 15.0%, reach more than $17.8 billion by 2011.
Related Reports
Global Markets and Technologies for Home Medical Equipment
The global market for home medical equipment (HME) was worth $17.9 billion in 2010, nearly $19 billion in 2011, and is expected to reach $26.2 billion by 2016, a CAGR of 6.7%.
Global Markets for Telemedicine Technologies
The global telemedicine market is expected to grow from $9.8 billion in 2010 to $11.6 billion in 2011, and to $27.3 billion in 2016, a compound annual growth rate (CAGR) of 18.6% over the next five years.
Medical Automation Technologies, Products and Markets
The U.S. market for medical automation technologies was worth an estimated $13 billion in 2010. BCC expects this market to grow to $13.3 billion in 2011 and $21 billion by 2016, a compound annual growth rate (CAGR) of 9.5% over the next 5 years.
Microelectronic Medical Implants: Products, Technologies & Opportunities
The global market for microelectronic medical implants, accessories, and supplies was worth an estimated $15.4 billion in 2010. The market is projected to grow to $16.3 billion in 2011 and $24.8 billion in 2016, a compound annual growth rate (CAGR) of 8.8%, between 2011 and 2016.
Recent Reports
Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets
The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.
Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials
The global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028.
Global Cleanroom Technology Market
The global market for cleanroom products is expected to grow from $7.5 billion in 2023 to $10.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.
Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets
The global market for ophthalmic devices, diagnostics and surgical equipment is expected to grow from $32.5 billion in 2023 and forecast to reach $44.0 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2028.
Microelectromechanical Systems (MEMS) in Global Medical Markets
The global market for microelectromechanical systems (MEMS) devices in medical applications is estimated to increase from $4.8 billion in 2023 to reach $7.2 billion by 2028, at a compound annual growth rate (CAGR) of 8.5% from 2023 through 2028.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
Flame Retardant Chemicals: Technologies and Global Markets
The global consumption of flame retardant chemicals is estimated to grow from 6.0 billion pounds in 2022 to 7.5 billion pounds in 2027, at a compound annual growth rate (CAGR) of 4.4% for the period of 2022-2027.
Biorefinery Products: Global Markets
The global market for biorefinery products is estimated to increase from $624.7 billion in 2022 to $920.0 billion by 2027, at a compound annual growth rate (CAGR) of 8.0% from 2022 through 2027.
Electric Vehicle Charging: Infrastructure and Global Markets
The global market for wired electric vehicle charging infrastructure is estimated to grow from $24.1 billion in 2022 to $81.1 billion in 2027, at a compound annual growth rate (CAGR) of 27.4% for the period of 2022-2027.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More